Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients
Clinical trial NCT07021261 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07021261
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-16
- Primary completion
- 2030-06-16
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.